We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SCBFY:OTCStandard Chartered PLC Analysis

Data as of 2026-05-14 - not real-time

$51.78

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Standard Chartered PLC is trading in a bullish technical environment, with the short‑term moving average comfortably above the mid‑term average and the long‑term average also trailing lower, reinforcing upward momentum. The relative strength index sits in the upper half of its range, while the MACD line has crossed above its signal, both suggesting continued price strength. Volume is on an upward trend, supporting the price advance toward the identified resistance zone.
Fundamentally, the bank delivers solid revenue growth and attractive operating margins, coupled with a dividend yield near the sector norm and a modest payout ratio, indicating dividend sustainability. Valuation metrics present a mixed picture: earnings multiples are below the industry average, yet the price‑to‑book ratio is elevated, implying a balanced view on fair value. The combination of strong cash reserves, manageable debt levels, and a diversified geographic footprint underpins a resilient earnings outlook despite heightened market volatility.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover confirming momentum
  • RSI positioned in the upper half, supporting upward bias
  • Increasing volume reinforcing the price move

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Steady revenue growth and healthy operating margins
  • Sustainable dividend with low payout ratio
  • Mixed valuation signals and elevated price‑to‑book ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust cash position and manageable debt profile
  • Diversified global presence reducing concentration risk
  • Consistent dividend policy enhancing total return potential

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin26.05%
P/E Ratio12.5
ROE10.11%
ROA0.59%
P/B Ratio25.9
Industry P/E16.4

Technical Analysis

TrendBullish
RSI60.8
Support$47.06
Resistance$52.67
MA 20$49.86
MA 50$46.29
MA 200$44.11
MACDBullish
VolumeIncreasing
Fear & Greed Index89.5

Valuation

Target Price$55.50
Upside/Downside7.18%
GradeFair
TypeBlend
Dividend Yield2.36%

Risk Assessment

Beta1.33
Volatility41.93%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.